Fixed-dose combination of ivabradine and metoprolol in a patient with stable coronary artery disease: a case report
https://doi.org/10.15829/1560-4071-2021-4657
Abstract
This article discusses a case of using fixed-dose combination of ivabradine/metoprolol in actual clinical practice.
References
1. Karpov YuA, Glezer MG, Vasyuk YuA, et al. Antianginal effectiveness and tolerability of ivabradine in patients with stable angina: CONTROL-2 Study results. Cardiovascular Therapy and Prevention. 2011;10(8):83-9. (In Russ.)
2. Knuuti J, Wijns W, Saraste A, et al.; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407-77. doi:10.1093/eurheartj/ehz425. Erratum in: Eur Heart J. 2020;41(44):4242.
3. Russian Society of Cardiology (RSC). 2020 Clinical practice guidelines for Stable coronary artery disease. Russian Journal of Cardiology. 2020;25(11):4076. (In Russ.) doi:10.15829/1560-4071-2020-4076.
4. Divchev D, Stöckl G; study investigators. Effectiveness and Impact on Adherence of a New Fixed-Dose Combination of Ivabradine and Metoprolol in a Wide Range of Stable Angina Patients in Real-Life Practice. Cardiol Ther. 2019;8(2):317-28. doi:10.1007/s40119-019-00145-7.
5. Werdan K, Ebelt H, Nuding S, et al. Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study. Clin Res Cardiol. 2012;101:365-73. doi:10.1007/s00392-011-0402-4.
6. Zarifis J, Kallistratos M, Katsivas A, on behalf of the investigators of the Prospective, Non-interventional, Observational Study of the Antianginal Efficacy of Ivabradine During a 4-Month Treatment of a Greek Population With Coronary Artery Disease. Antianginal Efficacy of Ivabradine/Metoprolol Combination in Patients With Stable Angina. Clinical Cardiology. 2016;39(12):697-702. doi:10.1002/clc.22585.
7. Gilarevskii SR, Lantsova EV, Akimov AA. Efficacy and Safety of Combined Treatment with Ivabradine and Metoprolol in Patients with Stable Angina Pectoris — a Systematic Review. Kardiologiia. 2020;60(11):101-9. (In Russ.) doi:10.18087/cardio.2020.11.n1357.
8. Fox KM; EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362(9386):782-8. doi:10.1016/s0140-6736(03)14286-9.
9. Karpov YuA. Perindopril: clinical efficacy in all patients with vascular disease or its high risk through vasoprotection. Consilium medicum. 2009;1:51-5. (In Russ.)
Review
For citations:
Shimkevich A.M. Fixed-dose combination of ivabradine and metoprolol in a patient with stable coronary artery disease: a case report. Russian Journal of Cardiology. 2021;26(9):4657. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4657
Views:
552
Email this article 